Validation of the Treatment Satisfaction Questionnaire for Medication in patients with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 11, Issue 6, 2012, Pages 494-501

  Regnault, Antoine ^a   Balp, Maria Magdalena ^b   Kulich, Károly ^a   Viala Danten, Muriel ^b  

^a Mapi Consultancy   (France)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Cystic fibrosis; Patient compliance; Patient satisfaction; Questionnaires; Tobramycin

Indexed keywords

TOBRAMYCIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONSTRUCT VALIDITY; CYSTIC FIBROSIS; DISCRIMINANT VALIDITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTERNAL CONSISTENCY; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; NEBULIZER; PATIENT COMPLIANCE; PATIENT SATISFACTION; POWDER INHALER; PRESCHOOL CHILD; PSEUDOMONAS INFECTION; PSYCHOMETRY; QUESTIONNAIRE; RELIABILITY; SCHOOL CHILD; TREATMENT SATISFACTION QUESTIONNAIRE WITH MEDICATION; UNSPECIFIED SIDE EFFECT; VALIDATION STUDY;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; CHILD; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; NEBULIZERS AND VAPORIZERS; PATIENT SATISFACTION; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PSYCHOMETRICS; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; TOBRAMYCIN; YOUNG ADULT;

EID: 84869087512     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.04.007     Document Type: Article

References (34)

1. Regnault A., Balp M.M., Kulich K., Estève L., Viala-Danten M. Validation of the treatment satisfaction questionnaire for medication (TSQM) in cystic fibrosis (CF). J Cyst Fibros 2011, 10:S85.
2. Regnault A., Balp M.M., Kulich K., Estève L., Viala-Danten M. Association of treatment satisfaction and compliance of cystic fibrosis patients using inhaled tobramycin treatment in the EAGER study. J Cyst Fibros 2011, 10:S82.
3. Corey M., Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 1996, 143:1007-1017.
4. Pritt B., O'Brien L., Winn W. Mucoid Pseudomonas in cystic fibrosis. Am J Clin Pathol 2007, 128:32-34.
5. Kerem E., Bentur L., England S., Reisman J., O'Brodovich H., Bryan A.C., et al. Sequential pulmonary function measurements during treatment of infantile chronic interstitial pneumonitis. J Pediatr 1990, 116:61-67.
6. Flume P.A., O'Sullivan B.P., Robinson K.A., Goss C.H., Mogayzel P.J., Willey-Courand D.B., et al. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med 2007, 176:957-969.
7. Heijerman H., Westerman E., Conway S., Touw D., Doring G. Inhaled medication and inhalation devices for lung disease in patients with cystic fibrosis: a European consensus. J Cyst Fibros 2009, 8:295-315.
8. Modi A.C., Quittner A.L. Barriers to treatment adherence for children with cystic fibrosis and asthma: what gets in the way?. J Pediatr Psychol 2006, 31:846-858.
9. Sawicki G.S., Sellers D.E., Robinson W.M. High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cyst Fibros 2009, 8:91-96.
10. Atkinson M.J., Kumar R., Cappelleri J.C., Hass S.L. Hierarchical construct validity of the treatment satisfaction questionnaire for medication (TSQM version II) among outpatient pharmacy consumers. Value Health 2005, 8(Suppl. 1):S9-S24.
11. Shikiar R., Rentz A.M. Satisfaction with medication: an overview of conceptual, methodologic, and regulatory issues. Value Health 2004, 7:204-215.
12. Weaver M., Patrick D.L., Markson L.E., Martin D., Frederic I., Berger M. Issues in the measurement of satisfaction with treatment. Am J Manag Care 1997, 3:579-594.
13. Regnault A., Viala-Danten M., Gilet H., Berdeaux G. Scoring and psychometric properties of the Eye-Drop Satisfaction Questionnaire (EDSQ), an instrument to assess satisfaction and compliance with glaucoma treatment. BMC Ophthalmol 2010, 10:1.
14. Keininger D., Coteur G. Assessment of self-injection experience in patients with rheumatoid arthritis: psychometric validation of the Self-Injection Assessment Questionnaire (SIAQ). Health Qual Life Outcomes 2011, 9:2.
15. Campbell J.L., Kiebert G.M., Partridge M.R. Development of the satisfaction with inhaled asthma treatment questionnaire. Eur Respir J 2003, 22:127-134.
16. Schurmann W., Schmidtmann S., Moroni P., Massey D., Qidan M. Respimat Soft Mist inhaler versus hydrofluoroalkane metered dose inhaler: patient preference and satisfaction. Treat Respir Med 2005, 4:53-61.
17. Volovitz B., Duenas-Meza E., Chmielewska-Szewczyk D.A., Kosa L., Astafieva N.G., Villaran C., et al. Comparison of oral montelukast and inhaled cromolyn with respect to preference, satisfaction, and adherence: a multicenter, randomized, open-label, crossover study in children with mild to moderate persistent asthma. Curr Ther Res Clin Exp 2000, 61:490-506.
18. Maspero J.F., Duenas-Meza E., Volovitz B., Pinacho D.C., Kosa L., Vrijens F., et al. Oral montelukast versus inhaled beclomethasone in 6- to 11-year-old children with asthma: results of an open-label extension study evaluating long-term safety, satisfaction, and adherence with therapy. Curr Med Res Opin 2001, 17:96-104.
19. Stoloff S., Samuels S., Kerney D., Brown C.P. Management of chronic obstructive pulmonary disease associated with chronic bronchitis with inhaled fluticasone propionate/salmeterol (ADVAIR DISKUS) 250/50: results of a patient experience trial. MedGenMed 2006, 8:86.
20. Cappelleri J.C., Gerber R.A., Kourides I.A., Gelfand R.A. Development and factor analysis of a questionnaire to measure patient satisfaction with injected and inhaled insulin for type 1 diabetes. Diabetes Care 2000, 23:1799-1803.
21. Cappelleri J.C., Cefalu W.T., Rosenstock J., Kourides I.A., Gerber R.A. Treatment satisfaction in type 2 diabetes: a comparison between an inhaled insulin regimen and a subcutaneous insulin regimen. Clin Ther 2002, 24:552-564.
22. Goss C.H., Quittner A.L. Patient-reported outcomes in cystic fibrosis. Proc Am Thorac Soc 2007, 4:378-386.
23. Knudson R.J., Lebowitz M.D., Holberg C.J., Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983, 127:725-734.
24. Konstan M.W., Flume P.A., Kappler M., Chiron R., Higgins M., Brockhaus F., et al. Safety, efficacy and convenience of tobramycin inhalation powder in cystic fibrosis patients: the EAGER trial. J Cyst Fibros 2011, 10:54-61.
25. Atkinson M.J., Sinha A., Hass S.L., Colman S.S., Kumar R.N., Brod M., et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health Qual Life Outcomes 2004, 2:12.
26. Campbell D.T., Fiske D.W. Convergent and discriminant validation by the multitrait-multimethod matrix. Psychol Bull 1959, 56:81-105.
27. Nunnally J.C., Bernstein I.H. Psychometric theory 1994, McGraw-Hill Inc, New York. 3rd ed.
28. Holland P.W., Wainer H. Differential Item Functioning 1993, Lawrence Erlbaum Associates, Newbury Park, NJ.
29. Zumbo B. A handbook on the theory and methods of differential item functioning (DIF): Logistic regression as a unitary framework for binary and Likert-type (ordinal) item scores 1999, Directorate of Human Research and Evaluation, Department of National Defense, Ottawa, ON.
30. Kline R.B. Principle and Practice of Structural Equation Modeling 2005, Guilford Press, New York. 2nd ed.
31. Foddy W. Constructing Questions for Interviews and Questionnaires: Theory and Practice in Social Research 1993, Cambridge University Press, Cambridge.
32. Oliver R.L. Satisfaction: A Behavioral Perspective on the Consumer 1997, McGraw-Hill, New York.
33. Cramer J.A., Roy A., Burrell A., Fairchild C.J., Fuldeore M.J., Ollendorf D.A., et al. Medication compliance and persistence: terminology and definitions. Value Health 2008, 11:44-47.
34. Osterberg L., Blaschke T. Adherence to medication. N Engl J Med 2005, 353:487-497.